Neonatal liver disease

Karan McBride Emerick1, Peter F Whitington

  • 1Division of Gastroenterology, Hepatology, and Nutrition, Children's Memorial Hospital, Northwestern University School of Medicine, Chicago, IL, USA. k-emerick@northwestern.edu

Pediatric Annals
|April 28, 2006
PubMed

Insights

Rapid diagnosis of neonatal liver disease is crucial. Pediatricians should evaluate jaundice in infants over 2 weeks old using bilirubin measurements to ensure timely intervention and improve outcomes.

Area of Science:

  • Pediatrics
  • Neonatology
  • Hepatology

Background:

  • Neonatal liver disease diagnosis requires prompt identification.
  • Early detection relies on recognizing jaundice and abnormal stool/urine color.
  • Timely intervention is critical for improving infant outcomes.

Purpose of the Study:

  • To establish a rapid and accurate diagnostic approach for neonatal liver disease.
  • To guide physicians in appropriate and timely diagnostic testing.
  • To facilitate early referral to pediatric gastroenterology.

Main Methods:

  • Evaluating jaundice in infants older than 2 weeks.
  • Measuring fractionated bilirubin levels.
  • Utilizing a diagnostic algorithm based on specific bilirubin thresholds.

Main Results:

  • Direct bilirubin levels above 1.0 mg/dL (total < 5.0 mg/dL) warrant further assessment.
  • Direct bilirubin >20% of total bilirubin (total > 5.0 mg/dL) indicates the need for evaluation.
  • A diagnostic algorithm aids in timely testing and referral.

Conclusions:

  • A structured diagnostic approach is essential for neonatal liver disease.
  • Early identification and management significantly impact patient outcomes.
  • Physician awareness and diagnostic algorithms improve the care of infants with liver disease.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...